AC Immune SA
F:IMR
AC Immune SA
F:IMR
Price:
2.37
EUR
0.42%
Market Closed
Market Cap:
€235.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AC Immune SA
F:IMR
|
CH |
|
Wincanton PLC
F:5K2
|
UK |
|
Choom Holdings Inc
F:ORO
|
CA |
|
S
|
Sarytogan Graphite Ltd
ASX:SGA
|
AU |
|
H
|
HocMon Trade JSC
VN:HTC
|
VN |
|
Radius Health Inc
NASDAQ:RDUS
|
US |
|
Schindler Holding AG
SIX:SCHP
|
CH |
|
Verusa Holding AS
IST:VERUS.E
|
TR |
|
I
|
Indika Energy Tbk PT
XMUN:I41
|
ID |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
Wall St Price Targets
IMR Price Targets Summary
AC Immune SA
AC Immune SA
Wall Street analysts forecast IMR stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for IMR is 7.86 EUR with a low forecast of 4.63 EUR and a high forecast of 10.69 EUR.
Lowest Forecast
Price Target
4.63
EUR
95% Upside
Average Forecast
Price Target
7.86
EUR
232% Upside
Highest Forecast
Price Target
10.69
EUR
351% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMR's stock price target?
Price Target
7.86
EUR
7.86
EUR
According to Wall Street analysts, the average 1-year price target for IMR is 7.86 EUR with a low forecast of 4.63 EUR and a high forecast of 10.69 EUR.
What is the Revenue forecast for AC Immune SA?
Projected CAGR
86%
86%
Over the last 11 years, the compound annual growth rate for Revenue has been -18%. The projected CAGR for the next 5 years is 86%.
